SAD pharmaceuticals generally cover patients with special needs, and in many cases they cannot be purchased from the industry. Therefore, they are an important component in the supply of pharmaceuticals for hospitals. There are many changes in the lifecycle of a pharmaceutical.
In collaboration with the hospital pharmacies, Amgros makes sure that drugs comply with all the relevant rules and standards. This helps secure high quality and safety for patients. Amgros is responsible for submitting amended documentation to the Danish Medicines Agency for marketing licences for around 60 SAD pharmaceuticals.
Photographer: Anne-Li Engström
SAD pharmaceuticals are manufactured at two of the eight hospital pharmacies. Amgros supports production by coordinating complaints management. We deal with administrative tasks regarding labelling, packaging and shelf life.
On behalf of the hospital pharmacies, Amgros procures many of the raw materials used by hospital pharmacies in their production. This saves resources at the individual hospital pharmacy. We analyse the market and ensure the correct quality of the raw materials delivered for hospital pharmacy production. We do this by coordinating audits of suppliers. We also check that suppliers live up to current regulations and standards, and that they have documentation in place.
Amgros monitors SAD pharmaceuticals to enhance safety for various patient groups and in situations where the drugs are used in combination with other drugs. In addition to studies of the literature on the area, this work includes information from patients, physicians, the pharmaceuticals industry and authorities in Denmark and abroad.
If the hospital pharmacies change the way they manufacture a pharmaceutical, or if monitoring of pharmaceuticals gives rise to changes in how clinics use or manage the pharmaceutical, we will send a variation application to the Danish Medicines Agency. Amgros will also update the product summary for the pharmaceutical, and communicate the changes to the clinical pharmacists.
Read more
Horizon Scanning
With Horizon Scanning, Amgros creates a comprehensive overview of new medicines and indication extensions expected to be marketed in Denmark within the next two to three years. This overview enables the Danish Medicines Council to plan its work well in advance. At the same time, it provides Amgros with a stronger basis for preparing upcoming price negotiations with suppliers and organising tendering procedures. We also prepare financial estimates that give the regions a solid foundation for planning their medicine budgets. These estimates take into account both new, often more expensive treatments and potential savings when lower-cost alternatives enter the market.
READ MOREPrice negotiations and tendering
Amgros is responsible for the procurement of the majority of medicines used in public Danish hospitals. In addition, we negotiate prices for selected medicines for the primary healthcare sector.
READ MORE
Procurement and supply
Amgros informs the hospital pharmacies when we have set up an agreement to purchase a pharmaceutical. After this, hospital pharmacies send their purchase orders to the supplier
READ MORE